Back

L-DOPA treatment promotes sustained neurovascular and synaptichomeostasis in the diabetic retina

Chlan, E.; Li, C.; Bales, K.; Wood, L. B.; Pardue, M.

2026-02-18 neuroscience
10.64898/2026.02.17.706466 bioRxiv
Show abstract

While previous work has shown a sustained protective effect of levodopa (L-DOPA) on retinal function in early-stage diabetic retinopathy (DR) in humans, its underlying biology is unknown. Using noninvasive measures in diabetic mice, we found L-DOPA protects retinal neurovascular function as measured by oscillatory potential timing and flicker-evoked retinal vasodilation, as well as visual behavior, for at least two weeks past treatment end. Assessing changes in retinal gene expression, differentially expressed genes were broadly comparable between diabetic mice experiencing washout of L-DOPA versus continued L-DOPA treatment, with gene co-expression network analysis identifying distinct modules across L-DOPA-treated diabetic mice associated with synaptic function and cytoskeletal organization that correlated with functional protection. Together, these findings demonstrate that L-DOPA restores and sustains retinal neurovascular function in early DR and links this protection to transcriptional programs supporting synapse activity and structural integrity. TeaserL-DOPA restores neuronal and vascular performance in the diabetic retina, with benefits that lasted after treatment stopped.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.